Celmatix Announces Achievement of Key Preclinical Milestones in Premature Menopause Prevention Drug Program

May 16

Written By Colleen McMillen

Colleen McMillen

Celmatix Appoints Women’s Health Pioneer Dr. Bart CJM Fauser to Chairmanship of Scientific Advisory Board and Newly Formed Clinical Trial Steering Committee

Celmatix Achieves Milestone for PCOS Drug Program